Targeting the NLRP3 inflammasome in psoriasis
International Journal of Dermatology · 2024-07 · 63 (7) · 844-851
DOI: 10.1111/ijd.17073 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Dermatology, online erschienen am 12.02.2024. Verfasst von Xiuhui Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Precision Pharmacy and Pharmaceutical Basic Research, Dongguan, China. Hauptthemen laut MEDLINE: Psoriasis, NLR Family, Pyrin Domain-Containing 3 Protein, Inflammasomes. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: School of Pharmaceutical Sciences in Guangzhou Medical University, Guangzhou Medical University.
Abstract (Originalsprache)
The NLRP3 inflammasome, a complex consisting of the nucleotide‐binding oligomerization domain, leucine‐rich repeat, and pyrin domain‐containing protein 3, has emerged as a critical mediator of pathological inflammation and a significant therapeutic target for various inflammatory diseases. Psoriasis, a chronic inflammatory skin condition without a definitive cure, has shown promising results in animal models through the inhibition of the NLRP3 inflammasome. This review aims to explore the development of the NLRP3 inflammasome in psoriasis and the molecular mechanisms responsible for its inhibition by natural products and small molecules currently being developed for psoriasis treatment. Furthermore, we are examining clinical trials using agents that block the NLRP3 pathway for the treatment of psoriasis. This study is timely to provide a new perspective on managing psoriasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Precision Pharmacy and Pharmaceutical Basic Research, Dongguan, China.
- Department of Pharmacy, Dongguan Eighth People's Hospital, Dongguan Children's Hospital Affiliated to Guangdong Medical University, Dongguan, China.
- Key Laboratory of Molecular Target & Clinical Pharmacology and the State & NMPA Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences & the Fifth Affiliated Hospital, Guangzhou Medical University, Gua…
- Department of Pharmacy, Baoan Central Hospital of Shenzhen, Shenzhen, China.
ORCID-Profile: Xiuhui Chen
Förderung
- School of Pharmaceutical Sciences in Guangzhou Medical University
- Guangzhou Medical University
Zitieren
APA
Chen, X., Deng, G., Chen, K., Chen, Y., Ye, W., & Sun, P. (2024). Targeting the NLRP3 inflammasome in psoriasis. International Journal of Dermatology, 63(7), 844-851. https://doi.org/10.1111/ijd.17073
Vancouver
Chen X, Deng G, Chen K, Chen Y, Ye W, Sun P. Targeting the NLRP3 inflammasome in psoriasis. International Journal of Dermatology. 2024;63(7):844-851. doi:10.1111/ijd.17073
BibTeX
@article{Chen2024,
author = {Chen, Xiuhui and Deng, Guoliang and Chen, Kaifeng and Chen, Yanhong and Ye, Weijun and Sun, Ping},
title = {Targeting the NLRP3 inflammasome in psoriasis},
journal = {International Journal of Dermatology},
year = {2024},
volume = {63},
number = {7},
pages = {844--851},
doi = {10.1111/ijd.17073}
}
EUVIMED